MOLICHEM MEDICINES INC has a total of 31 patent applications. Its first patent ever was published in 1994. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are NOVALAR PHARMACEUTICALS INC, PHYTOTECH LTD and ENTEC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | Canada | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Australia | 2 | |
#6 | China | 1 | |
#7 | Japan | 1 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Peptides | |
#5 | Fermentation | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Molina Luis | 23 |
#2 | Henke David C | 7 |
#3 | Stutts Monroe Jackson | 7 |
#4 | Romeo Charles J | 6 |
#5 | Molina Y Vedia Luis Miguel | 4 |
#6 | Kazmierski Wieslaw Mieczyslaw | 4 |
#7 | Boucher Jr Richard C | 4 |
#8 | Boucher Richard C Jr | 2 |
#9 | Molina Y Vedia Luis M | 2 |
#10 | Vedia Luis M Molina Y | 1 |
Publication | Filing date | Title |
---|---|---|
EP1753445A2 | Treatment of ocular diseases and disorders using lantibiotic compositions | |
CA2565457A1 | Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions | |
AU2003275129A1 | Nucleic acids encoding duramycin | |
CN1700894A | Methods of treating dry eye disease with lantibiotics |